{"DataElement":{"publicId":"2180612","version":"1","preferredName":"Lymphoma Ann Arbor Lymphoma Staging System Classification Stage","preferredDefinition":"the classification of the severity of lymphoma disease following journal-described criteria from an Ann Arbor, Michigan study series which has been modified for additional staging.","longName":"LYM_ANNAR_CLASS_STG","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195817","version":"1","preferredName":"Lymphoma Ann Arbor Lymphoma Staging System Classification","preferredDefinition":"information related to the Ann Arbor lymphoma staging classification system.","longName":"LYMPH_ANNARBOR_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177031","version":"1","preferredName":"Lymphoma","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003","longName":"Lymphoma","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A90-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177585","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"Classification","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51A1-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDCFEC55-15A7-6809-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2180611","version":"1","preferredName":"Lymphoma Ann Arbor Lymphoma Staging System Classification Stage","preferredDefinition":"the classification of the severity of lymphoma disease following journal-described criteria from an Ann Arbor, Michigan study.","longName":"LYM_ANNAR_CLASS_STG","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"I","valueDescription":"I","ValueMeaning":{"publicId":"2558891","version":"1","preferredName":"I","longName":"2558891","preferredDefinition":"Stage I","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B318-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5C20-2AD9-0875-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"IE","valueDescription":"IE","ValueMeaning":{"publicId":"2568248","version":"1","preferredName":"IE","longName":"2568248","preferredDefinition":"Stage IE (lymphoma only)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7A5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"CURTIST","dateModified":"2007-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5C20-2ADC-0875-E034-0003BA12F5E7","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"II","valueDescription":"II","ValueMeaning":{"publicId":"2565932","version":"1","preferredName":"II","longName":"2565932","preferredDefinition":"Stage II","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CE99-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-05-09","modifiedBy":"CURTIST","dateModified":"2007-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5C20-2ADF-0875-E034-0003BA12F5E7","beginDate":"2004-01-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"IIE","valueDescription":"IIE","ValueMeaning":{"publicId":"2568249","version":"1","preferredName":"IIE","longName":"2568249","preferredDefinition":"Stage IIE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7A6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"CURTIST","dateModified":"2007-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5C20-2AE2-0875-E034-0003BA12F5E7","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"III","valueDescription":"III","ValueMeaning":{"publicId":"2558915","version":"1","preferredName":"III","longName":"2558915","preferredDefinition":"Stage III","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B330-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2009-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5C20-2AE5-0875-E034-0003BA12F5E7","beginDate":"2004-01-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"IIIE","valueDescription":"IIIE","ValueMeaning":{"publicId":"2568250","version":"1","preferredName":"IIIE","longName":"2568250","preferredDefinition":"Stage IIIE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7A7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"CURTIST","dateModified":"2009-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5881-2B3D-0877-E034-0003BA12F5E7","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"IIIS","valueDescription":"IIIS","ValueMeaning":{"publicId":"2568251","version":"1","preferredName":"IIIS","longName":"2568251","preferredDefinition":"Stage IIIS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7A8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"CURTIST","dateModified":"2009-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5881-2B41-0877-E034-0003BA12F5E7","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"IIIE+S","valueDescription":"IIIE+S","ValueMeaning":{"publicId":"2568491","version":"1","preferredName":"IIIE+S","longName":"2568491","preferredDefinition":"IIIE+S","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D898-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"PWEST","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5881-2B45-0877-E034-0003BA12F5E7","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"IV","valueDescription":"IV","ValueMeaning":{"publicId":"2559008","version":"1","preferredName":"IV","longName":"2559008","preferredDefinition":"Stage IV","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B38D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2009-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D1FC5881-2B48-0877-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"III or IV","valueDescription":"Ann Arbor Stage III Lymphoma Or Ann Arbor Stage IV Lymphoma","ValueMeaning":{"publicId":"6775279","version":"1","preferredName":"Ann Arbor Stage III Lymphoma Or Ann Arbor Stage IV Lymphoma","longName":"6775279","preferredDefinition":"Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S).: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Stage III Lymphoma","conceptCode":"C8320","definition":"Ann Arbor Classification: Stage III: Involvement of lymph node regions on both sides of the diaphragm (III), which also may be accompanied by extralymphatic extension in association with adjacent lymph node involvement (IIIE) or by involvement of the spleen (IIIS) or both (IIIE,S).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ann Arbor Stage IV Lymphoma","conceptCode":"C8321","definition":"Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow, lungs (other than by direct extension from another site), or cerebrospinal fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A9CEBAE-1983-3D32-E053-F662850AF9B2","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A9CEBAE-199C-3D32-E053-F662850AF9B2","beginDate":"2019-06-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"},{"value":"I or II","valueDescription":"Ann Arbor Stage I Lymphoma Or Ann Arbor Stage II Lymphoma","ValueMeaning":{"publicId":"6775282","version":"1","preferredName":"Ann Arbor Stage I Lymphoma Or Ann Arbor Stage II Lymphoma","longName":"6775282","preferredDefinition":"Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma).: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Stage I Lymphoma","conceptCode":"C8318","definition":"Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ann Arbor Stage II Lymphoma","conceptCode":"C8319","definition":"Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A9CEBAE-19AC-3D32-E053-F662850AF9B2","latestVersionIndicator":"Yes","beginDate":"2019-06-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A9CEBAE-19C5-3D32-E053-F662850AF9B2","beginDate":"2019-06-06","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-06-06","modifiedBy":"ONEDATA","dateModified":"2019-06-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D1FC7648-8CA7-093B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"MORENOC","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"-COMMENT","type":"COMMENT","description":"Add instruction: at Study Entry (*Note: Where specified by protocol, replace Ann Arbor Classification with Murphy stage.)","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Preferred Question Text","description":"Modified Ann Arbor Stage","url":null,"context":"CTEP"},{"name":"9177 alt question text","type":"Alternate Question Text","description":"Has any stages of disease","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Ann Arbor stage","url":null,"context":"Alliance"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Ann Arbor Stage of disease","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D1FC7648-8CAB-093B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-28","modifiedBy":"MORENOC","dateModified":"2019-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}